Dr. Beth Ann Helmink, MD

Dr. Helmink practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Helmink's NPI, 1740547066, was assigned on April 12, 2012. Dr. Helmink graduated from WashU Medicine in 2012. Dr. Helmink holds Texas license R0867.

Dr. Helmink's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Helmink's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Helmink practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Helmink's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Helmink is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Dr. Helmink's licenses on file in 12 states: Texas, Florida, Arizona, Tennessee, Washington, Alabama, Georgia, Louisiana, Mississippi, Oklahoma, Illinois and Missouri.

Dmand AI lists colon removal among the conditions Dr. Helmink treats.

CMS data shows 94 Medicare services from Dr. Helmink across 4 procedure codes in 2024, for 78 Medicare patients. Medicare paid $8,477 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 78 Medicare patients who saw Dr. Helmink in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Helmink's median patient age at 67, with 59% women.

In 2024, Dr. Helmink wrote 25 Medicare Part D claims. 88% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Helmink for performance year 2024, reported as part of a group. Dr. Helmink accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Helmink as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 57 papers to Dr. Helmink, published from 2006 to 2025. 2021 was the busiest year, with 6. The most frequent topics are Gastrointestinal Microbiome, Immunotherapy and Cell Cycle Proteins. Dr. Helmink has published most often in Ann Surg Oncol. Dr. Helmink's most frequent co-authors are Jennifer A. Wargo, MD, Michael Geoffrey White, MD and Neal Bhutiani, MD, PhD.

Dr. Helmink graduated from WashU Medicine in 2012.

Dr. Helmink is in network with 5 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.